Radiofrequency coblation for the resection of head and neck malignancies

Carney, A. Simon; Timms, M. S.; Marnane, Conor; Krishnan, Suren; Rees, Guy; Mirza, Showkat

doi:10.1016/j.otohns.2007.08.022

Cited by 30 publications

(34 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Coblation has also been used for endoscopic resection of head and neck malignancies with decreased operative times. 6 Histologic evaluation of coblation injury to the vocal fold has demonstrated several points in considering the safety of coblation for removal of lesions from human vocal folds. When examining the effects of various intensities and applications of the coblation wand, the injury pattern can be generalized …”

Section: Discussionmentioning

confidence: 99%

Coblation of the Canine Vocal Fold: A Histologic Study

et al. 2012

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Coblation of the Canine Vocal Fold: A Histologic Study

et al. 2012

View full text Add to dashboard Cite

“…It has been reported for use on adenoidectomy, nasopharyngeal angiofibromas, sinonasal polyposis, laryngotracheal recurrent respiratory papillomas and turbinate reduction [1][2][3][4][5] . Radiofrequency coblation removes tissue by molecular disintegration.…”

Section: Introductionmentioning

confidence: 99%

Radiofrequency Coblation Decreases Blood Loss during Endoscopic Sinonasal and Skull Base Tumor Removal

Kostrzewa¹,

Sunde²,

Riley

et al. 2010

ORL

View full text Add to dashboard Cite

Background/Aims: Minimizing bleeding during transnasal resections of sinonasal tumors is imperative for optimizing visualization and decreasing complications. The purpose of the present study was to determine whether radiofrequency coblation decreases blood loss during endoscopic tumor removal. Methods: Sinonasal/skull base tumors treated in 2008 with endoscopic techniques were reviewed. The data collected included demographics, histopathology, technique, duration, complications and estimated blood loss (EBL). Full operative videoendoscopy was available in all cases and scored by the authors using the 11-point Wormald surgical field grading scale. Results: Twenty-three patients (average age: 46 years) with sinonasal or skull base tumors treated with transnasal endoscopic techniques were identified. Coblation was used in 10 cases. The sinus/skull base tumors included were esthesioneuroblastoma (n = 6), melanoma (n = 3), squamous cell carcinoma (n = 3), inverted papilloma (n = 3), adenocarcinoma (n = 2), intracranial dermoid cyst (n = 2), adenoid cystic carcinoma (n = 1), craniopharyngioma (n = 1), fibromyxosarcoma (n = 1) and undifferentiated carcinoma (n = 1). The use of the coblation device was associated with a significant decrease in all categories including EBL (350 vs. 1,000 ml; p = 0.0001), EBL per operative time (66 vs. 166 ml/h; p = 0.0001) and Wormald grade (3.3 vs. 6.4; p = 0.0001). Conclusion: Radiofrequency coblation significantly decreased blood loss during endoscopic tumor removal and is a useful tool in the armamentarium of the endoscopic skull base surgeon.

show abstract

“…6 In the larynx and trachea, the technology has also been used for the treatment of recurrent laryngotracheal papillomatosis, laryngeal cysts and malignancy. 3,4,7 Coblation technology is based on bipolar radiofrequency, with the addition of saline applied over the electrodes. This produces a localised, high-energy plasma field, which ablates tissue into low-molecular weight gases and seals blood vessels at the same time, with minimal adjacent thermal effect.…”

Section: Discussionmentioning

confidence: 99%

“…Its use in otolaryngology, and head and neck surgery is increasing. [3][4][5][6][7] In a direct response to surgeons' requests, a dedicated laryngeal coblation wand was introduced onto the market in 2004; the success of this wand for the treatment of laryngeal pathology has since been established. 3,4 However, as yet, there has been no published data on its use for the treatment of laryngotracheal stenosis.…”

Section: Introductionmentioning

confidence: 99%